A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy
Public ClinicalTrials.gov record NCT03941964. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Single-Arm, Multicenter Open-Label Study of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in AML Patients Ineligible for Intensive Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study evaluating the effectiveness and safety of venetoclax, in combination with azacitidine or decitabine, in an outpatient setting for treatment-naïve participants with AML who are ineligible for intensive chemotherapy.
Study identification
- NCT ID
- NCT03941964
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 15, 2019 (Actual)
- Primary completion
- Mar 14, 2022 (Actual)
- Completion
- Mar 14, 2022 (Actual)
- Last update posted
- Mar 20, 2023
2019 – 2022
United States locations
- U.S. sites
- 16
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates, PC-HOPE /ID# 211509 | Tempe | Arizona | 85284-1812 | — |
| Colorado Blood Cancer Institute /ID# 212800 | Denver | Colorado | 80218 | — |
| Rocky Mountain Cancer Centers /ID# 211508 | Lone Tree | Colorado | 80124 | — |
| Fort Wayne Medical Oncology /ID# 223523 | Fort Wayne | Indiana | 46804 | — |
| Minnesota Oncology Hematology, PA /ID# 212837 | Minneapolis | Minnesota | 55404 | — |
| Oncology Hematology Care, Inc. /ID# 212779 | Cincinnati | Ohio | 45236-2725 | — |
| Willamette Valley Cancer Institute and Research Center /ID# 211504 | Eugene | Oregon | 97401-6043 | — |
| Charleston Oncology, P.A. /ID# 211471 | Charleston | South Carolina | 29414-7710 | — |
| Prisma Health Cancer Inst - Eastside /ID# 211466 | Greenville | South Carolina | 29615 | — |
| Tennessee Oncology - Chattanooga / McCallie /ID# 212717 | Chattanooga | Tennessee | 37404-3230 | — |
| Tennessee Oncology-Nashville Centennial /ID# 210944 | Nashville | Tennessee | 37203-1632 | — |
| Texas Oncology - Austin Midtown /ID# 212780 | Austin | Texas | 78705 | — |
| Texas Oncology - Medical City Dallas /ID# 211503 | Dallas | Texas | 75230 | — |
| Texas Transplant Institute /ID# 213311 | San Antonio | Texas | 78229 | — |
| Texas Oncology - San Antonio Medical Center /ID# 211510 | San Antonio | Texas | 78240-5251 | — |
| Texas Oncology - Northeast Texas /ID# 213908 | Tyler | Texas | 75702 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03941964, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03941964 live on ClinicalTrials.gov.